½ÃÀ庸°í¼­
»óǰÄÚµå
1587157

¼¼°èÀÇ ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå : À¯Çü, ¸ðµâ, ÃÖÁ¾ »ç¿ëÀÚ, Àü°³º° ¿¹Ãø(2025-2030³â)

Clinical Workflow Solution Market by Type, Module, End-User, Deployment - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 194 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 98¾ï 4,000¸¸ ´Þ·¯, 2024³â¿¡´Â 111¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 14.32%·Î ¼ºÀåÇØ 2030³â¿¡´Â 251¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç(CWS)Àº ÀÇ·á ȯ°æ¿¡¼­ ÇÁ·Î¼¼½º¸¦ ÃÖÀûÈ­Çϱâ À§ÇØ ¼³°èµÇ¾úÀ¸¸ç, ÀÓ»ó ÀÛ¾÷À» È¿À²È­Çϰí, ¿À·ù¸¦ ÁÙÀ̰í, ȯÀÚ ÄÉ¾î °á°ú¸¦ °³¼±Çϱâ À§ÇÑ °ÍÀÔ´Ï´Ù. ȯÀÚ ¼ö Áõ°¡, ±ÔÁ¦ ¿ä±¸ »çÇ× ¹× ÀÓ»ó °á°ú °³¼±ÀÇ Çʿ伺À¸·Î °Ç°­ °ü¸® ½Ã¼³¿¡¼­ ÇÕ¸®È­ µÈ ¾÷¹«¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ ¼Ö·ç¼ÇÀº º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ¼­ºñ½º µî ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡ Àû¿ëµÇ¸ç ÀÇ·á Á¦°ø¾÷ü, °ü¸®ÀÚ ¹× Á÷¿øÀÌ È¯ÀÚ °ü¸®¸¦ È¿À²ÀûÀ¸·Î Á¶Á¤ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¼ö ÀÖ½À´Ï´Ù ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§´Â ÀϹÝÀûÀ¸·Î ÀÀ±Þ½Ç, ¼ö¼ú, ¹æ»ç¼±°ú, ½ÇÇè½Ç µî, ÀÛ¾÷ÀÇ Á¶Á¤ÀÌ Áß¿äÇÑ ºÎ¹®¿¡ À̸£±â±îÁö, ½ÃÀåÀÇ ¼ºÀå, ±â¼úÀÇ Áøº¸, ÇコÄɾî IT ½Ã½ºÅÛÀÇ µµÀÔ È®´ë, ȯÀÚ Áß½ÉÀÇ ÄɾîÀÇ Á߽à µî ¿äÀο¡ Å©°Ô ¿µÇâÀ» ¹Þ½À´Ï´Ù. AI ÅëÇÕ ¹× ½Ç½Ã°£ ºÐ¼® µµ±¸¿Í °°Àº ÃÖ±Ù µ¿ÇâÀº ¿öÅ©Ç÷οì ÀÚµ¿È­ ¹× ¿¹Ãø ºÐ¼® ±â´ÉÀ» °­È­ÇÏ´Â ºñÁî´Ï½ºÀÔ´Ï´Ù. ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷Àº ±âÁ¸ º´¿ø Á¤º¸ ½Ã½ºÅÛ°ú ¿øÈ°ÇÏ°Ô ÅëÇÕ ÇÒ ¼öÀÖ´Â »óÈ£ ¿î¿ë °¡´ÉÇÏ°í »ç¿ëÇϱ⠽¬¿î ½Ã½ºÅÛÀ» ±¸ÃàÇÏ´Â µ¥ ÁÖ·ÂÇØ¾ßÇÕ´Ï´Ù., ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼Ç, ¿ø°Ý ÀÇ·á¿ÍÀÇ ÅëÇÕ°ú °°Àº ºÎ¹®ÀÇ Çõ½ÅÀº °æÀï·ÂÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü ¹× ÀÌÇØ°ü°èÀÚ¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» ÅëÇÑ ¸ÂÃãÇü ¼Ö·ç¼Çµµ À¯¸ÁÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯¸ÁÇÑ ¼ºÀå¿¡µµ ºÒ±¸ÇÏ°í ½ÃÀåÀº ±Þ¼ÓÇÑ Çõ½Å°ú ¾ö°ÝÇÑ ±ÔÁ¦¸¦ Ư¡À¸·Î Çϸç Áö¼ÓÀûÀÎ R&D ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ ±â¾÷Àº ȯÀÚ µ¥ÀÌÅ͸¦ º¸È£Çϱâ À§ÇØ ÁøÈ­ÇÏ´Â »çÀ̹ö º¸¾È »óȲÀ» ÇØ°áÇØ¾ßÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºÎ¹®¿¡ Á¾»çÇÔÀ¸·Î½á ±â¾÷Àº µðÁöÅÐÈ­¿Í µ¥ÀÌÅÍÈ­°¡ ÁøÇàµÇ´Â °Ç°­ °ü¸® ½ÃÀå¿¡¼­ Áö¼Ó °¡´ÉÇÑ ¼ºÀå°ú Çõ½ÅÀ» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 98¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 111¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 251¾ï 3,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 14.32%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÇÁ·Î¼¼½º ÅëÇÕ¿¡ ÀÇÇÑ È¯ÀÚ Äɾî¿Í ¾ÈÀü¼ºÀÇ Çâ»ó
    • Àǻ翡°Ô ½Ç½Ã°£ ¹®¼­È­ ¹× ÅëÇÕ ¿öÅ©ÇÃ·Î¿ì °ü¸®
    • HCIT µµÀÔÀ» À§ÇÑ Á¤ºÎÀÇ ´ëó
    • ¸¸¼º ÁúȯÀÇ ¸¸¿¬¿¡ ÀÇÇÑ È¯ÀÚ¼ö Áõ°¡¿¡ ´ëÇÑ È¿°úÀûÀÎ °ü¸®
    • ÀÇ·á ¹× À繫 ½Ç¼ö °¨¼Ò
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀÓ»ó Á¤º¸Çп¡ °üÇÑ Àü¹® Áö½ÄÀÇ ºÎÁ·
    • Á¾·¡ÀÇ °üÇàÀÇ »ç¿ë¿¡ ÀÇÇÑ ¼Ò±Ø¼º
  • ½ÃÀå ±âȸ
    • ÅëÇÕµÈ ¿öÅ©Ç÷οì ÀÎÅÚ¸®Àü½º
    • ÀÇ»ç ´ë ȯÀÚ ºñÀ²ÀÇ ³·À½¿¡ ÀÇÇÑ Ã¤¿ë Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • IT ÀÎÇÁ¶ó¿¡ ´ëÇÑ °í¾×ÀÇ Ãʱâ ÅõÀÚ
    • »óÈ£ ¿î¿ë¼º ¹× µ¥ÀÌÅÍ º¸¾È ¹®Á¦

Porter's Five Forces : ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ÀÓ»ó ¿öÅ© Ç÷Π¼Ö·ç¼Ç ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½ÃÀû ȯ°æ ¿äÀÎÀº ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ À־ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀÓ»ó ¿öÅ© ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÇÁ·Î¼¼½º ÅëÇÕ¿¡ ÀÇÇÑ È¯ÀÚ Äɾî¿Í ¾ÈÀü¼ºÀÇ Çâ»ó
      • Àǻ翡°Ô ½Ç½Ã°£ ¹®¼­È­ ¹× ÅëÇÕ ¿öÅ©ÇÃ·Î¿ì °ü¸®
      • HCIT µµÀÔÀ» À§ÇÑ Á¤ºÎÀÇ ´ëó
      • ¸¸¼º Áúȯ Áõ°¡¿¡ ¼ö¹ÝÇϴ ȯÀÚ ¼ö Áõ°¡¿¡ ´ëÇÑ È¿°úÀûÀÎ °ü¸®
      • ÀÇ·á ¹× À繫 ½Ç¼ö °¨¼Ò
    • ¾ïÁ¦¿äÀÎ
      • ÀÓ»ó Á¤º¸ÇÐÀÇ Àü¹® Áö½ÄÀÌ ÇÑÁ¤µÇ¾î ÀÖ´Ù
      • Á¾·¡ÀÇ °üÇàÀÇ »ç¿ë¿¡ ÀÇÇÑ ÀúÇ×
    • ±âȸ
      • ÅëÇÕ ¿öÅ©Ç÷οì ÀÎÅÚ¸®Àü½º
      • ÀÇ»ç¿Í ȯÀÚÀÇ ºñÀ²ÀÌ ³·±â ¶§¹®¿¡ µµÀÔÀÌ Áõ°¡
    • °úÁ¦
      • IT ÀÎÇÁ¶ó¿¡ ´ëÇÑ Ãʱâ ÅõÀÚ¾×ÀÌ ³ô´Ù
      • »óÈ£ ¿î¿ë¼º ¹× µ¥ÀÌÅÍ º¸¾È ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå : À¯Çüº°

  • Äɾî Äݶ󺸷¹ÀÌ¼Ç ¼Ö·ç¼Ç
    • Åõ¾à °ü¸® ¼Ö·ç¼Ç
    • ÁÖ»ê±â ÄÉ¾î °ü¸® ¼Ö·ç¼Ç
    • ¹Ý¿Ã¸² ¼Ö·ç¼Ç
  • µ¥ÀÌÅÍ ÅëÇÕ ¼Ö·ç¼Ç
    • EMR ÅëÇÕ ¼Ö·ç¼Ç
    • ÀÇ·á À̹ÌÁö ÅëÇÕ ¼Ö·ç¼Ç
  • ¿£ÅÍÇÁ¶óÀÌÁî º¸°í¼­ ¹× ºÐ¼® ¼Ö·ç¼Ç
  • ½Ç½Ã°£ Ä¿¹Â´ÏÄÉÀÌ¼Ç ¼Ö·ç¼Ç
    • °£È£»ç È£Ã⠰溸 ½Ã½ºÅÛ
    • ÅëÇÕ Ä¿¹Â´ÏÄÉÀÌ¼Ç ¼Ö·ç¼Ç
  • ¿öÅ©Ç÷οì ÀÚµ¿È­ ¼Ö·ç¼Ç
    • °£È£ ¹× Á÷¿ø ½ºÄÉÁÙ ¼Ö·ç¼Ç
    • ȯÀÚ È帧 °ü¸® ¼Ö·ç¼Ç

Á¦7Àå ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå : ¸ðµâº°

  • Á÷¿ø ¿Âº¸µù
  • ¼ÛÀå ½ÂÀÎ
  • ±¸¸Å¿äû

Á¦8Àå ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡ Áø·á ¼¾ÅÍ
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø

Á¦9Àå ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå : Àü°³º°

  • Ŭ¶ó¿ìµå»ó
  • ¿ÂÇÁ·¹¹Ì½º

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼Ç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Allscripts Healthcare Solutions, Inc.
  • American Well Corporation
  • Ascom Holding AG
  • Baxter International, Inc.
  • Cerner Corporation by Oracle Corporation
  • Cisco Systems, Inc.
  • Cybage Software Pvt. Ltd.
  • GE Healthcare
  • Hill-Rom Services, Inc.
  • Koninklijke Philips NV
  • Mckesson Corporation
  • Novarad Corporation
  • Spok Inc.
  • Stanley Black & Decker, Inc.
BJH 24.11.15

The Clinical Workflow Solution Market was valued at USD 9.84 billion in 2023, expected to reach USD 11.17 billion in 2024, and is projected to grow at a CAGR of 14.32%, to USD 25.13 billion by 2030.

Clinical Workflow Solutions (CWS) are designed to optimize processes in healthcare settings, aiming to improve the efficiency of clinical tasks, reduce errors, and enhance patient care outcomes. The necessity of CWS lies in the growing demand for streamlined operations in healthcare facilities, driven by increased patient inflow, regulatory requirements, and the need for improved clinical outcomes. These solutions find application across various healthcare settings, including hospitals, clinics, and ambulatory services, and can be utilized by healthcare providers, administrators, and staff to coordinate patient care efficiently. The end-use scope typically extends to departments like emergency rooms, surgery, radiology, and laboratories where the coordination of tasks is crucial. Market growth is greatly influenced by factors such as technological advancements, the increasing adoption of healthcare IT systems, and an emphasis on patient-centric care. However, challenges such as high implementation costs, resistance to adopting new technologies, and concerns over data privacy and security pose significant limitations. Recent developments, such as AI integration and real-time analytics tools, offer potential opportunities for businesses to enhance workflow automation and predictive analytics capabilities. To capitalize on these opportunities, companies should focus on creating interoperable and user-friendly systems that can seamlessly integrate with existing hospital information systems. Innovation in areas like cloud-based solutions, mobile applications, and telemedicine integration can offer a competitive edge. Furthermore, partnerships with healthcare providers and stakeholders for customized solutions appear promising. Despite the promising growth, the market is characterized by rapid technological changes and stringent regulatory constraints, requiring continuous research and development investments. Businesses should also address the evolving cybersecurity landscape to safeguard patient data. By addressing these areas, companies can ensure sustainable growth and innovation in the increasingly digital and data-driven healthcare market.

KEY MARKET STATISTICS
Base Year [2023] USD 9.84 billion
Estimated Year [2024] USD 11.17 billion
Forecast Year [2030] USD 25.13 billion
CAGR (%) 14.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Workflow Solution Market

The Clinical Workflow Solution Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Enhanced patient care and safety due to process integration
    • Real-time documentation and integrated workflow management to physicians
    • Government initiatives for HCIT adoption
    • Effective management of increasing patient volume due to the rising prevalence of chronic diseases
    • Reduction in medical and financial errors
  • Market Restraints
    • Limited expertise in clinical informatics
    • Reluctance due to use of conventional practices
  • Market Opportunities
    • Integrated workflow intelligence
    • Rising adoption due to the low doctor-to-patient ratio
  • Market Challenges
    • High initial investments in IT infrastructure
    • Interoperability and data security issues

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Workflow Solution Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Workflow Solution Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Workflow Solution Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Workflow Solution Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Workflow Solution Market

A detailed market share analysis in the Clinical Workflow Solution Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Workflow Solution Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Workflow Solution Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Workflow Solution Market

A strategic analysis of the Clinical Workflow Solution Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Workflow Solution Market, highlighting leading vendors and their innovative profiles. These include Allscripts Healthcare Solutions, Inc., American Well Corporation, Ascom Holding AG, Baxter International, Inc., Cerner Corporation by Oracle Corporation, Cisco Systems, Inc., Cybage Software Pvt. Ltd., GE Healthcare, Hill-Rom Services, Inc., Koninklijke Philips N.V., Mckesson Corporation, Novarad Corporation, Spok Inc., and Stanley Black & Decker, Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Workflow Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Care Collaboration Solutions, Data Integration Solutions, Enterprise Reporting & Analytics Solutions, Real-Time Communication Solutions, and Workflow Automation Solutions. The Care Collaboration Solutions is further studied across Medication Administration Solutions, Perinatal Care Management Solutions, and Rounding Solutions. The Data Integration Solutions is further studied across EMR Integration Solutions and Medical Image Integration Solutions. The Real-Time Communication Solutions is further studied across Nurse Call Alert Systems and Unified Communication Solutions. The Workflow Automation Solutions is further studied across Nursing & Staff Scheduling Solutions and Patient Flow Management Solutions.
  • Based on Module, market is studied across Employee Onboarding, Invoice Approval, and Purchase Request.
  • Based on End-User, market is studied across Ambulatory Care Centers, Home Care Settings, and Hospitals.
  • Based on Deployment, market is studied across On-Cloud and On-Premise.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Enhanced patient care and safety due to process integration
      • 5.1.1.2. Real-time documentation and integrated workflow management to physicians
      • 5.1.1.3. Government initiatives for HCIT adoption
      • 5.1.1.4. Effective management of increasing patient volume due to the rising prevalence of chronic diseases
      • 5.1.1.5. Reduction in medical and financial errors
    • 5.1.2. Restraints
      • 5.1.2.1. Limited expertise in clinical informatics
      • 5.1.2.2. Reluctance due to use of conventional practices
    • 5.1.3. Opportunities
      • 5.1.3.1. Integrated workflow intelligence
      • 5.1.3.2. Rising adoption due to the low doctor-to-patient ratio
    • 5.1.4. Challenges
      • 5.1.4.1. High initial investments in IT infrastructure
      • 5.1.4.2. Interoperability and data security issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Workflow Solution Market, by Type

  • 6.1. Introduction
  • 6.2. Care Collaboration Solutions
    • 6.2.1. Medication Administration Solutions
    • 6.2.2. Perinatal Care Management Solutions
    • 6.2.3. Rounding Solutions
  • 6.3. Data Integration Solutions
    • 6.3.1. EMR Integration Solutions
    • 6.3.2. Medical Image Integration Solutions
  • 6.4. Enterprise Reporting & Analytics Solutions
  • 6.5. Real-Time Communication Solutions
    • 6.5.1. Nurse Call Alert Systems
    • 6.5.2. Unified Communication Solutions
  • 6.6. Workflow Automation Solutions
    • 6.6.1. Nursing & Staff Scheduling Solutions
    • 6.6.2. Patient Flow Management Solutions

7. Clinical Workflow Solution Market, by Module

  • 7.1. Introduction
  • 7.2. Employee Onboarding
  • 7.3. Invoice Approval
  • 7.4. Purchase Request

8. Clinical Workflow Solution Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Home Care Settings
  • 8.4. Hospitals

9. Clinical Workflow Solution Market, by Deployment

  • 9.1. Introduction
  • 9.2. On-Cloud
  • 9.3. On-Premise

10. Americas Clinical Workflow Solution Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Workflow Solution Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Workflow Solution Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allscripts Healthcare Solutions, Inc.
  • 2. American Well Corporation
  • 3. Ascom Holding AG
  • 4. Baxter International, Inc.
  • 5. Cerner Corporation by Oracle Corporation
  • 6. Cisco Systems, Inc.
  • 7. Cybage Software Pvt. Ltd.
  • 8. GE Healthcare
  • 9. Hill-Rom Services, Inc.
  • 10. Koninklijke Philips N.V.
  • 11. Mckesson Corporation
  • 12. Novarad Corporation
  • 13. Spok Inc.
  • 14. Stanley Black & Decker, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦